Keyphrases
Glucagon-like
100%
Type 2 Diabetes Mellitus (T2DM)
64%
Type 2 Diabetic Patients
38%
Skeletal muscle
35%
Insulin
34%
Glucagon
33%
Glucose-dependent Insulinotropic Polypeptide
28%
Obesity
25%
Insulin Secretion
24%
Insulin Sensitivity
23%
Insulin Resistance
22%
Type 1 Diabetes Mellitus (T1DM)
20%
Atrial Fibrillation
18%
Diabetes
18%
Type I Diabetes
16%
B Cells
16%
Glucagon-like peptide-1 (GLP-1)
16%
Weight Loss
15%
Incretin Hormones
15%
Positron Emission Tomography
15%
Medicine and Dentistry
Glucagon Like Peptide 1
50%
Maturity Onset Diabetes of the Young
47%
Skeletal Muscle
35%
Gastric Inhibitory Polypeptide
23%
Insulin Release
22%
Patient with Type 2 Diabetes
22%
Incretin
21%
Neoplasm
21%
Beta Cell
20%
Insulin Sensitivity
20%
Diabetes
20%
positron emission tomographic scan
19%
Secretion (Process)
17%
Diabetes Mellitus
16%
Diseases
15%
Glucagon Like Peptide 2
15%
Insulin Resistance
15%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-1
51%
Skeletal Muscle
47%
Insulin Release
35%
Blood Plasma
29%
Glucagon
28%
Gastric Inhibitory Polypeptide
27%
Secretion (Process)
22%
Insulin Resistance
21%
Insulin Sensitivity
20%
Incretin
20%
Allele
19%
Glucose Blood Level
17%
Messenger RNA
17%
Atrial Fibrillation
15%